These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11163637)

  • 1. A selective phosphodiesterase IV inhibitor, rolipram blocks both withdrawal behavioral manifestations, and c-Fos protein expression in morphine dependent mice.
    Hamdy MM; Mamiya T; Noda Y; Sayed M; Assi AA; Gomaa A; Yamada K; Nabeshima T
    Behav Brain Res; 2001 Jan; 118(1):85-93. PubMed ID: 11163637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of cyclic AMP systems in morphine physical dependence in mice: prevention of development of morphine dependence by rolipram, a phosphodiesterase 4 inhibitor.
    Mamiya T; Noda Y; Ren X; Hamdy M; Furukawa S; Kameyama T; Yamada K; Nabeshima T
    Br J Pharmacol; 2001 Mar; 132(5):1111-7. PubMed ID: 11226142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphodiesterase 4 inhibitors, rolipram and diazepam block the adaptive changes observed during morphine withdrawal in the heart.
    González-Cuello A; Sánchez L; Hernández J; Teresa Castells M; Victoria Milanés M; Laorden ML
    Eur J Pharmacol; 2007 Sep; 570(1-3):1-9. PubMed ID: 17601555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Type IV phosphodiesterase inhibitor rolipram interferes with drug-induced conditioned place preference but not immediate early gene induction in mice.
    Thompson BE; Sachs BD; Kantak KM; Cherry JA
    Eur J Neurosci; 2004 May; 19(9):2561-8. PubMed ID: 15128409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of rolipram and diazepam on the adaptive changes induced by morphine withdrawal in the hypothalamic paraventricular nucleus.
    Núñez C; González-Cuello A; Sánchez L; Vargas ML; Milanés MV; Laorden ML
    Eur J Pharmacol; 2009 Oct; 620(1-3):1-8. PubMed ID: 19683523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanisms in dizocilpine-induced attenuation of development of morphine dependence: an association with cortical Ca2+/calmodulin-dependent signal cascade.
    Hamdy MM; Noda Y; Miyazaki M; Mamiya T; Nozaki A; Nitta A; Sayed M; Assi AA; Gomaa A; Nabeshima T
    Behav Brain Res; 2004 Jul; 152(2):263-70. PubMed ID: 15196794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A neuroactive steroid, dehydroepiandrosterone sulfate, prevents the development of morphine dependence and tolerance via c-fos expression linked to the extracellular signal-regulated protein kinase.
    Ren X; Noda Y; Mamiya T; Nagai T; Nabeshima T
    Behav Brain Res; 2004 Jul; 152(2):243-50. PubMed ID: 15196791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of rolipram, a selective inhibitor of phosphodiesterase 4, on hyperlocomotion induced by several abused drugs in mice.
    Mori T; Baba J; Ichimaru Y; Suzuki T
    Jpn J Pharmacol; 2000 Jun; 83(2):113-8. PubMed ID: 10928323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. c-Fos and peptide immunoreactivities in the central extended amygdala of morphine-dependent rats after naloxone-precipitated withdrawal.
    Veinante P; Stoeckel ME; Lasbennes F; Freund-Mercier MJ
    Eur J Neurosci; 2003 Sep; 18(5):1295-305. PubMed ID: 12956728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of cyclic AMP-specific phosphodiesterase 4 activation during naloxone-precipitated morphine withdrawal in rats.
    Kimura M; Tokumura M; Itoh T; Inoue O; Abe K
    Neurosci Lett; 2006 Aug; 404(1-2):107-11. PubMed ID: 16753260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The contribution of supraspinal, peripheral and intrinsic spinal circuits to the pattern and magnitude of Fos-like immunoreactivity in the lumbar spinal cord of the rat withdrawing from morphine.
    Rohde DS; McKay WR; Chang DS; Abbadie C; Basbaum AI
    Neuroscience; 1997 Sep; 80(2):599-612. PubMed ID: 9284361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naloxone-precipitated morphine withdrawal elicits increases in c-fos mRNA expression in restricted regions of the infant rat brain.
    Maeda T; Kishioka S; Inoue N; Shimizu N; Fukazawa Y; Ozaki M; Yamamoto H
    Jpn J Pharmacol; 2002 Nov; 90(3):270-5. PubMed ID: 12499582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of rolipram, a phosphodiesterase IV inhibitor, on allergic footpad swelling using various adjuvants in mice.
    Yamaki K; Alam AH; Hossain MA; Taneda S; Yanagisawa R; Takano H; Yoshino S
    Scand J Immunol; 2005 Oct; 62(4):378-84. PubMed ID: 16253125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of c-Fos in the rat central amygdala accompanies the acquisition but not expression of conditioned place aversion induced by withdrawal from acute morphine dependence.
    Jin C; Araki H; Nagata M; Shimosaka R; Shibata K; Suemaru K; Kawasaki H; Gomita Y
    Behav Brain Res; 2005 Jun; 161(1):107-12. PubMed ID: 15904717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of 3',5'-cyclic adenosine monophosphate-dependent protein kinase in regulation of Fos expression and tyrosine hydroxylase levels during morphine withdrawal in the hypothalamic paraventricular nucleus and medulla oblongata catecholaminergic cell groups.
    Benavides M; Laorden ML; Milanés MV
    J Neurochem; 2005 Jan; 92(2):246-54. PubMed ID: 15663473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of different xanthines and phosphodiesterase inhibitors on c-fos expression in rat striatum.
    Svenningsson P; Johansson B; Fredholm BB
    Acta Physiol Scand; 1995 May; 154(1):17-24. PubMed ID: 7572198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rolipram: a specific phosphodiesterase 4 inhibitor with potential antipsychotic activity.
    Kanes SJ; Tokarczyk J; Siegel SJ; Bilker W; Abel T; Kelly MP
    Neuroscience; 2007 Jan; 144(1):239-46. PubMed ID: 17081698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphine withdrawal precipitated by specific mu, delta or kappa opioid receptor antagonists: a c-Fos protein study in the rat central nervous system.
    Le Guen S; Gestreau C; Besson JM
    Eur J Neurosci; 2003 Jun; 17(11):2425-37. PubMed ID: 12814374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential involvement of 3', 5'-cyclic adenosine monophosphate-dependent protein kinase in regulation of Fos and tyrosine hydroxylase expression in the heart after naloxone induced morphine withdrawal.
    Almela P; Cerezo M; González-Cuello A; Milanés MV; Laorden ML
    Naunyn Schmiedebergs Arch Pharmacol; 2007 Jan; 374(4):293-303. PubMed ID: 17216288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rolipram, a phosphodiesterase 4 inhibitor, stimulates inducible cAMP early repressor expression in osteoblasts.
    Cho ES; Yu JH; Kim MS; Yim M
    Yonsei Med J; 2005 Feb; 46(1):149-54. PubMed ID: 15744818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.